ABCL · ISSUER CIK 1703057
AbCellera Biologics Inc.
Between Jul 31, 2026 and Oct 28, 2026, 3 AbCellera Biologics Inc. insiders reported $1.5M of open-market purchases and $0.00 of sales on SEC Form 4. The largest buyer was Hayden Michael R (Director), with $1.1M.
↗3 insiders filed
Original Form 4 filings from Jul 31, 2026 to Oct 28, 2026. No open-market sales in the window.
$1.5MInsider buying
$0.00Insider selling
+$1.5MNet open-market
Aug 24, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 24, 202617:21 | Aug 24, 2026 | ABCL | Director | P · Buy | $10.64 | +53,613 | 1,373,397 | +4% | +$570K | -11.4% | +28.2% |
| Aug 18, 202614:45 | Aug 18, 2026 | ABCL | Director | P · Buy | $11.03 | +10,000 | 251,000 | +4% | +$110K | -3.1% | +23.7% |
| Aug 14, 202612:04 | Aug 14, 2026 | ABCL | Chief Financial Officer | P · Buy | $10.32 | +37,200 | 482,800 | +8% | +$384K | -5.9% | +32.2% |
| Aug 14, 202611:50 | Aug 12, 2026 | ABCL | Director | P · Buy | $10.37 | +46,387 | 1,319,784 | +4% | +$481K | +6.3% | +31.5% |
| Aug 13, 202615:01 | Aug 11, 2026 | ABCL | Director | G · Gift | — | −50,000 | 1,273,397 | -4% | — |